Signaling mechanisms of the myelin inhibitors of axon regeneration

Current Opinion in Neurobiology

Volumn 13, Issue 5, 2003, Pages 545-551

  Yiu, Glenn ^b   He, Zhigang ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPID; MYELIN INHIBITOR; NOGO 66 RECEPTOR ANTAGONIST; NOGO RECEPTOR ANTAGONIST; PROTEIN INHIBITOR; PROTEIN P75; RHO FACTOR; UNCLASSIFIED DRUG;

CENTRAL NERVOUS SYSTEM; DOWNSTREAM PROCESSING; FUNCTIONAL ASSESSMENT; IN VIVO STUDY; INHIBITION KINETICS; MOLECULE; NERVE FIBER REGENERATION; NONHUMAN; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROTEIN BINDING; REVIEW; SIGNAL TRANSDUCTION;

EID: 0344445378     PISSN: 09594388     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.conb.2003.09.006     Document Type: Review

References (67)

1. Schwab M.E., Thoenen H. Dissociated neurons regenerate into sciatic but not optic nerve explants in culture irrespective of neurotrophic factors. J. Neurosci. 5:1985;2415-2423.
2. Caroni P., Schwab M.E. Antibody against myelin-associated inhibitor of neurite growth neutralizes nonpermissive substrate properties of CNS white matter. Neuron. 1:1988;85-96.
3. Schnell L., Schwab M.E. Axonal regeneration in the rat spinal cord produced by an antibody against myelin-associated neurite growth inhibitors. Nature. 343:1990;269-272.
4. Prinjha R., Moore S.E., Vinson M., Blake S., Morrow R., Christie G., Michalovich D., Simmons D.L., Walsh F.S. Inhibitor of neurite outgrowth in humans. Nature. 403:2000;383-384.
5. Chen M.S., Huber A.B., van der Haar M.E., Frank M., Schnell L., Spillmann A.A., Christ F., Schwab M.E. Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature. 403:2000;434-439.
6. GrandPre T., Nakamura F., Vartanian T., Strittmatter S.M. Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein. Nature. 403:2000;439-444.
7. Fournier A.E., GrandPre T., Strittmatter S.M. Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration. Nature. 409:2001;341-346 This paper describes the identification of NgR as a high-affinity, functional receptor for Nogo-66.
8. McKerracher L., David S., Jackson D.L., Kottis V., Dunn R.J., Braun P.E. Identification of myelin-associated glycoprotein as a major myelin-derived inhibitor of neurite growth. Neuron. 13:1994;805-811.
9. Mukhopadhyay G., Doherty P., Walsh F.S., Crocker P.R., Filbin M.T. A novel role for myelin-associated glycoprotein as an inhibitor of axonal regeneration. Neuron. 13:1994;757-767.
10. Kottis V., Thibault P., Mikol D., Xiao Z.C., Zhang R., Dergham P., Braun P.E. Oligodendrocyte-myelin glycoprotein (OMgp) is an inhibitor of neurite outgrowth. J. Neurochem. 82:2002;1566-1569 As a follow-up of their previous work [8], this paper shows that OMgp accounts for a major activity of CNS myelin in inhibiting neurite outgrowths, also termed arretin.
11. Wang K.C., Koprivica V., Kim J.A., Sivasankaran R., Guo Y., Neve R.L., He Z. Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth. Nature. 417:2002;941-944 This paper describes the identification of OMgp as an additional myelin associated inhibitor in an attempt to identify growth cone-collapsing molecules in CNS myelin. In this paper, the authors also present evidence for NgR as a functional receptor of OMgp in inhibiting neurite outgrowth and inducing growth cone collapse.
12. Wang X., Chun S.J., Treloar H., Vartanian T., Greer C.A., Strittmatter S.M. Localization of Nogo-A and Nogo-66 receptor proteins at sites of axon-myelin and synaptic contact. J. Neurosci. 22:2002;5505-5515.
13. Jin W.L., Liu Y.Y., Liu H.L., Yang H., Wang Y., Jiao X.Y., Ju G. Intraneuronal localization of Nogo-A in the rat. J. Comp. Neurol. 458:2003;1-10.
14. Habib A.A., Marton L.S., Allwardt B., Gulcher J.R., Mikol D.D., Hognason T., Chattopadhyay N., Stefansson K. Expression of the oligodendrocyte-myelin glycoprotein by neurons in the mouse central nervous system. J. Neurochem. 70:1998;1704-1711.
15. Morgenstern D.A., Asher R.A., Fawcett J.W. Chondroitin sulphate proteoglycans in the CNS injury response. Prog. Brain Res. 137:2002;313-332.
16. Pizzorusso T., Medini P., Berardi N., Chierzi S., Fawcett J.W., Maffei L. Reactivation of ocular dominance plasticity in the adult visual cortex. Science. 298:2002;1248-1251.
17. ••] .
18. ••] report independent findings that NgR mediates the inhibitory activity of MAG, in addition to Nogo-66 and OMgp.
19. Fournier A.E., Gould G.C., Liu B.P., Strittmatter S.M. Truncated soluble Nogo receptor binds Nogo-66 and blocks inhibition of axon growth by myelin. J. Neurosci. 22:2002;8876-8883.
20. He X.L., Bazan J.F., McDermott G., Park J.B., Wang K., Tessier-Lavigne M., He Z., Garcia K.C. Structure of the nogo receptor ectodomain. A recognition module implicated in myelin inhibition. Neuron. 38:2003;177-185.
21. GrandPre T., Li S. Strittmatter SM: Nogo-66 receptor antagonist peptide promotes axonal regeneration. Nature. 417:2002;547-551 The authors find that a Nogo-66-derived peptide (NEP-140) is able to bind to NgR and to neutralize the inhibitory activity of Nogo-66 in vitro. In addition, this peptide, when applied in vivo, stimulates the regeneration of lesioned corticospinal tract and improves functional recovery.
22. Johnson P.W., Abramow-Newerly W., Seilheimer B., Sadoul R., Tropak M.B., Arquint M., Dunn R.J., Schachner M., Roder J.C. Recombinant myelin-associated glycoprotein confers neural adhesion and neurite outgrowth function. Neuron. 3:1989;377-385.
23. Cai D., Qiu J., Cao Z., McAtee M., Bregman B.S., Filbin M.T. Neuronal cyclic AMP controls the developmental loss in ability of axons to regenerate. J. Neurosci. 21:2001;4731-4739.
24. Vinson M., Strijbos P.J., Rowles A., Facci L., Moore S.E., Simmons D.L., Walsh F.S. Myelin-associated glycoprotein interacts with ganglioside GT1b. A mechanism for neurite outgrowth inhibition. J. Biol. Chem. 276:2001;20280-20285.
25. Vyas A.A., Patel H.V., Fromholt S.E., Heffer-Lauc M., Vyas K.A., Dang J., Schachner M., Schnaar R.L. Gangliosides are functional nerve cell ligands for myelin-associated glycoprotein (MAG), an inhibitor of nerve regeneration. Proc. Natl. Acad Sci. USA. 99:2002;8412-8417.
26. Yamashita T., Higuchi H., Tohyama M. The p75 receptor transduces the signal from myelin-associated glycoprotein to Rho. J. Cell Biol. 157:2002;565-570 This study provides initial evidence for the functional involvement of p75 in mediating the inhibitory activity of myelin components. Although MAG does not bind to p75, the neurons from p75 mutant mice are defective in responding to MAG both functionally (neurite outgrowth assay) and biochemically (RhoA activation).
27. ••] .
28. ••] describe evidence for a physical interaction between NgR and p75. The sensory neurons and cerebellar granule neurons from p75 knockout mice are defective in responding to Nogo-66, OMgp, and MAG. Consistent with the notion of p75 as a signal transducer, a truncated p75 lacking the intracellular domain, when overexpressed in neurons, attenuates the activity of MAG and other myelin inhibitors.
29. Walsh G.S., Krol K.M., Crutcher K.A., Kawaja M.D. Enhanced neurotrophin-induced axon growth in myelinated portions of the CNS in mice lacking the p75 neurotrophin receptor. J. Neurosci. 19:1999;4155-4168.
30. Ernfors P., Hallbook F., Ebendal T., Shooter E.M., Radeke M.J., Misko T.P., Persson H. Developmental and regional expression of beta-nerve growth factor receptor mRNA in the chick and rat. Neuron. 1:1988;983-996.
31. Roux P.P., Colicos M.A., Barker P.A., Kennedy T.E. p75 neurotrophin receptor expression is induced in apoptotic neurons after seizure. J. Neurosci. 19:1999;6887-6896.
32. Andsberg G., Kokaia Z., Lindvall O. Upregulation of p75 neurotrophin receptor after stroke in mice does not contribute to differential vulnerability of striatal neurons. Exp. Neurol. 169:2001;351-363.
33. Suzuki A., Nomura S., Morii E., Fukuda Y., Kosaka J. Localization of mRNAs for trkB isoforms and p75 in rat retinal ganglion cells. J. Neurosci. Res. 54:1998;27-37.
34. Ding J., Hu B., Tang L.S., Yip H.K. Study of the role of the low-affinity neurotrophin receptor p75 in naturally occurring cell death during development of the rat retina. Dev. Neurosci. 23:2001;390-398.
35. Hutson L.D., Bothwell M. Expression and function of Xenopus laevis p75(NTR) suggest evolution of developmental regulatory mechanisms. J. Neurobiol. 49:2001;79-98.
36. Vinson M., Rausch O., Maycox P.R., Prinjha R.K., Chapman D., Morrow R., Harper A.J., Dingwall C., Walsh F.S., Burbidge S.A., Riddell D.R. Lipid rafts mediate the interaction between myelin-associated glycoprotein (MAG) on myelin and MAG-receptors on neurons. Mol. Cell Neurosci. 22:2003;344-352 This study provides biochemical evidence that several signaling components, such as NgR, p75, RhoA, and GT1b, are associated with lipid rafts, suggesting that these proteins may form a receptor complex.
37. Jacobson K. Looking at lipid rafts? Trends Cell Biol. 9:1999;87-91.
38. Higuchi H., Yamashita T., Yoshikawa H., Tohyama M. PKA phosphorylates the p75 receptor and regulates its localization to lipid rafts. EMBO J. 22:2003;1790-1800 This paper describes interesting findings that activated p75 is re-localized to lipid rafts and phosphorylation of p75 by PKA regulates the relocation of p75.
39. Tansey M.G., Baloh R.H., Milbrandt J., Johnson E.M. Jr. GFRalpha-mediated localization of RET to lipid rafts is required for effective downstream signaling, differentiation, and neuronal survival. Neuron. 25:2000;611-623.
40. Ettienne-Manneville, Hall A. Rho GTPases in cell biology. Nature. 420:2002;629-635.
41. Shamah S.M., Lin M.Z., Goldberg J.L., Estrach S., Sahin M., Hu L., Bazalakova M., Neve R.L., Corfas G., Debant A., Greenberg M.E. EphA receptors regulate growth cone dynamics through the novel guanine nucleotide exchange factor ephexin. Cell. 105:2001;233-244.
42. Wong K., Ren X.R., Huang Y.Z., Xie Y., Liu G., Saito H., Tang H., Wen L., Brady-Kalnay S.M., Mei L., et al. Signal transduction in neuronal migration: roles of GTPase activating proteins and the small GTPase Cdc42 in the Slit-Robo pathway. Cell. 107:2001;209-221.
43. Swiercz J.M., Kuner R., Behrens J., Offermanns S. Plexin-B1 directly interacts with PDZ-RhoGEF/LARG to regulate RhoA and growth cone morphology. Neuron. 35:2002;51-63.
44. Aurandt J., Vikis H.G., Gutkind J.S., Ahn N., Guan K.L. The semaphorin receptor plexin-B1 signals through a direct interaction with the Rho-specific nucleotide exchange factor, LARG. Proc. Natl. Acad Sci. USA. 99:2002;12085-12090.
45. Lehmann M., Fournier A., Selles-Navarro I., Dergham P., Sebok A., Leclerc N., Tigyi G., McKerracher L. Inactivation of Rho signaling pathway promotes CNS axon regeneration. J. Neurosci. 19:1999;7537-7547.
46. Kuhn T.B., Brown M.D., Wilcox C.L., Raper J.A., Bamburg J.R. Myelin and collapsin-1 induce motor neuron growth cone collapse through different pathways: inhibition of collapse by opposing mutants of rac1. J. Neurosci. 19:1999;1965-1975.
47. Dergham P., Ellezam B., Essagian C., Avedissian H., Lubell W.D., McKerracher L. Rho signaling pathway targeted to promote spinal cord repair. J. Neurosci. 22:2002;6570-6577.
48. Winton M.J., Dubreuil C.I., Lasko D., Leclerc N., McKerracher L. Characterization of new cell permeable C3-like proteins that inactivate Rho and stimulate neurite outgrowth on inhibitory substrates. J. Biol. Chem. 277:2002;32820-32829.
49. Fournier A.E., Takizawa B.T., Strittmatter S.M. Rho kinase inhibition enhances axonal regeneration in the injured CNS. J. Neurosci. 23:2003;1416-1423.
50. Luo L. Rho GTPases in neuronal morphogenesis. Nat. Rev. Neurosci. 1:2000;173-180.
51. Yamashita T., Tucker K.L., Barde Y.A. Neurotrophin binding to the p75 receptor modulates Rho activity and axonal outgrowth. Neuron. 24:1999;585-593.
52. Yamashita T., Tohyama M. The p75 receptor acts as a displacement factor that releases Rho from Rho-GDI. Nat. Neurosci. 6:2003;461-467 In this study, the authors describe the identification of Rho-GDI as a missing link between p75 and RhoA. Myelin components, but not NGF, induced an interaction between p75 and Rho-GDI, which in turn dissociates Rho-GDI from Rho-GDP, allowing Rho-GDP to be activated by a yet unidentified GEF. In addition, a peptide that can inhibit the interaction between Rho-GDI and p75 is able to neutralize the myelin inhibition.
53. Bashaw G.J., Kidd T., Murray D., Pawson T., Goodman C.S. Repulsive axon guidance: Abelson and Enabled play opposing roles downstream of the roundabout receptor. Cell. 101:2000;703-715.
54. Aizawa H., Wakatsuki S., Ishii A., Moriyama K., Sasaki Y., Ohashi K., Sekine-Aizawa Y., Sehara-Fujisawa A., Mizuno K., Goshima Y., Yahara I. Phosphorylation of cofilin by LIM-kinase is necessary for semaphorin 3A-induced growth cone collapse. Nat. Neurosci. 4:2001;367-373.
55. Ming G., Song H., Berninger B., Inagaki N., Tessier-Lavigne M., Poo M. Phospholipase C-gamma and phosphoinositide 3-kinase mediate cytoplasmic signaling in nerve growth cone guidance. Neuron. 23:1999;139-148.
56. Song H., Poo M. The cell biology of neuronal navigation. Nat. Cell Biol. 3:2001;E81-E88.
57. Song H., Ming G., He Z., Lehmann M., McKerracher L., Tessier-Lavigne M., Poo M. Conversion of neuronal growth cone responses from repulsion to attraction by cyclic nucleotides. Science. 281:1998;1515-1518.
58. Cai D., Shen Y., De Bellard M., Tang S., Filbin M.T. Prior exposure to neurotrophins blocks inhibition of axonal regeneration by MAG and myelin via a cAMP-dependent mechanism. Neuron. 22:1999;89-101.
59. Qiu J., Cai D., Dai H., McAtee M., Hoffman P.N., Bregman B.S., Filbin M.T. Spinal axon regeneration induced by elevation of cyclic AMP. Neuron. 34:2002;895-903.
60. Neumann S., Bradke F., Tessier-Lavigne M., Basbaum A.I. Regeneration of sensory axons within the injured spinal cord induced by intraganglionic cAMP elevation. Neuron. 34:2002;885-893.
61. Cai D., Deng K., Mellado W., Lee J., Ratan R.R., Filbin M.T. Arginase I and polyamines act downstream from cyclic AMP in overcoming inhibition of axonal growth MAG and myelin in vitro. Neuron. 35:2002;711-719 The authors provide evidence that suggests that arginase I and polyamines participate in pathways downstream of cAMP elevation in reversing the inhibitory activity of MAG and perhaps other myelin components.
62. Bregman B.S., Kunkel-Bagden E., Schnell L., Dai H.N., Gao D., Schwab M.E. Recovery from spinal cord injury mediated by antibodies to neurite growth inhibitors. Nature. 378:1995;498-501.
63. ••].
64. ••].
65. ••] describe the phenotype analyses of Nogo knockout mice. Despite conflicting results, these studies suggest that blocking Nogo activity does not result in axon regeneration improvement as anticipated.
66. Steward O., Zheng B., Tessier-Lavigne M. False resurrections: distinguishing regenerated from spared axons in the injured central nervous system. J. Comp. Neurol. 459:2003;1-8 This review article provides a systematic analysis of published results on spinal cord injury models. The authors also suggest a series of criteria for assessing bona fide axon regeneration in these lesion models.
67. Dubreuil C., Winton M.J., McKerracher L. Rho activation patterns after spinal cord injury and the role of activated Rho in apoptosis in the central nervous system. J. Cell Biol. 162:2003;233-244.